FDA Approvals
The U.S. Food and Drug Administration recently expanded the use of a molecularly targeted therapeutic to include the treatment of certain patients with metastatic prostate cancer.
Learn More
The U.S. Food and Drug Administration recently expanded the use of a molecularly targeted therapeutic to include the treatment of certain patients with metastatic prostate cancer.
Learn More
Coronavirus Information and Resources: Learn how the COVID-19 pandemic has created special challenges for cancer patients, survivors, and their families.
Learn More
A combination of two immunotherapeutics has been approved to treat certain patients with non-small cell lung cancer, the most common type of lung cancer.
Learn More
Join the AACR in honoring all the researchers driving progress against cancer. #NCRM20 #ResearchSavesLives
Learn More
Lung cancer is the most common type of cancer with nearly 229,000 people living in the United States expected to be diagnosed this year. Learn about prevention, screening, and treatment options for lung cancer.
Learn More
An AACR grantee has identified a novel combination therapy for epithelial ovarian cancer.
Learn More
Join the AACR Runners for Research and support lifesaving cancer research by participating in virtual races and events around the country. Join the team as a virtual runner or create your own event.
Learn More
June 22-24
Registration for this virtual meeting, featuring a complete educational program as well as approximately 4,000 proffered papers on an e-poster platform, is free.
The American Association for Cancer Research (AACR) and our more than 47,000 members worldwide are advancing a scientifically bold agenda against the collection of devastating diseases we call cancer.
Learn MoreEva was devastated to learn her triple-negative breast cancer had spread to her lungs and sternum, but immunotherapy has allowed her and her husband to enjoy retirement together.
Learn MoreA physician-scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2018, to July 31, 2019
Learn MoreYour donation to the American Association for Cancer Research helps our more than 47,000 members worldwide drive progress against cancer.
Donate Today